- Sun Pharmaceutical Industries Limited announced its Q1 FY26 earnings, with sales reaching Rs. 1,37,861 million, a growth of 10.1% year-on-year.
- EBITDA for the quarter was Rs. 43,017 m…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]